Myung In Pharmaceutical LTD. (KRX:317450)
South Korea
· Delayed Price · Currency is KRW 58,700
-3,300 (-5.32%)
At close: Mar 9, 2026
KRX:317450 Market Cap
KRX:317450 has a market cap or net worth of 858.48 billion as of March 9, 2026.
Market Cap
858.48B
Enterprise Value
384.83B
Revenue
283.31B
Ranking
n/a
PE Ratio
9.18
Stock Price
58,700.00
Market Cap Chart
Since October 1, 2025, KRX:317450's market cap has decreased from 1.78T to 858.48B, a decrease of -51.76%. That is a compound annual growth rate of -81.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 9, 2026 | 858.48B | -14.66% |
| Dec 30, 2025 | 1,005.94B | -43.48% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samyang Biopharm | 632.05B |
| ImmuneOncia Therapeutics | 569.59B |
| HEM Pharma | 510.63B |
| G2GBIO | 1,569.81B |
| CellBion | 343.88B |
| DAE HWA Pharmaceutical | 238.75B |
| NOVAREX | 217.91B |
| Vivozon Pharmaceutical | 196.71B |